Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EDAPNYSE:NSPRNASDAQ:NXGLNASDAQ:OM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEDAPEdap Tms$1.77-1.7%$1.87$1.26▼$6.14$66.18M0.1398,311 shs19,549 shsNSPRInspireMD$2.53+11.0%$2.56$2.07▼$3.80$77.51M0.6238,006 shs38,347 shsNXGLNEXGEL$2.18-3.1%$2.66$1.84▼$5.10$16.69M0.6568,132 shs14,584 shsOMOutset Medical$17.95-2.8%$12.60$5.85▼$72.60$318.11M1.9105,417 shs112,546 shs10 Stocks Set to Soar in Spring 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEDAPEdap Tms-1.67%+0.57%+8.59%-31.40%-70.60%NSPRInspireMD+10.96%+7.20%-2.32%-20.69%+4.16%NXGLNEXGEL-3.11%-9.54%-19.26%-34.34%-6.44%OMOutset Medical-2.82%-7.95%+59.56%+36.70%-69.36%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEDAPEdap Tms2.0469 of 5 stars3.23.00.00.01.91.70.6NSPRInspireMD2.1057 of 5 stars3.50.00.00.01.52.50.6NXGLNEXGEL0.861 of 5 stars0.05.00.00.00.82.50.0OMOutset Medical1.1227 of 5 stars3.51.00.00.01.20.80.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEDAPEdap Tms 2.33Hold$8.50380.23% UpsideNSPRInspireMD 3.00Buy$4.5077.87% UpsideNXGLNEXGEL 0.00N/AN/AN/AOMOutset Medical 3.00Buy$27.0050.42% UpsideCurrent Analyst Ratings BreakdownLatest NXGL, OM, EDAP, and NSPR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/21/2025OMOutset MedicalRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSector Perform ➝ Sector Perform$14.00 ➝ $21.005/15/2025EDAPEdap TmsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral5/15/2025OMOutset MedicalScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/12/2025NSPRInspireMDPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$4.50 ➝ $4.005/8/2025OMOutset MedicalRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Perform ➝ Sector Perform$12.00 ➝ $14.004/4/2025EDAPEdap TmsJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold$8.00 ➝ $2.003/28/2025EDAPEdap TmsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$5.00 ➝ $4.503/28/2025EDAPEdap TmsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$19.00 ➝ $19.003/21/2025OMOutset MedicalStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$15.00(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEDAPEdap Tms$62.77M1.05N/AN/A$1.66 per share1.07NSPRInspireMD$7.03M11.03N/AN/A$1.83 per share1.38NXGLNEXGEL$10.23M1.63N/AN/A$0.90 per share2.42OMOutset Medical$115.27M2.76N/AN/A$2.45 per share7.33Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEDAPEdap Tms-$22.92M-$0.62N/AN/AN/A-34.92%-44.21%-25.88%N/ANSPRInspireMD-$19.92M-$0.79N/AN/AN/A-413.96%-69.42%-57.68%N/ANXGLNEXGEL-$3.16M-$0.45N/A∞N/A-52.60%-71.19%-34.79%N/AOMOutset Medical-$172.80M-$29.15N/A∞N/A-112.57%-175.64%-38.61%8/6/2025 (Estimated)Latest NXGL, OM, EDAP, and NSPR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025EDAPEdap Tms-$0.16-$0.20-$0.04-$0.20$16.56 million$16.37 million5/13/2025Q1 2025NXGLNEXGEL-$0.10-$0.09+$0.01-$0.09$2.73 million$2.81 million5/7/2025Q1 2025OMOutset Medical-$0.97-$3.66-$2.69-$3.66$27.81 million$29.75 million3/27/2025Q4 2024EDAPEdap Tms-$0.11-$0.05+$0.06-$0.05$20.83 million$22.69 million3/24/2025Q4 2024NXGLNEXGEL-$0.10-$0.08+$0.02-$0.11$2.99 million$3.04 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEDAPEdap TmsN/AN/AN/AN/AN/ANSPRInspireMDN/AN/AN/AN/AN/ANXGLNEXGELN/AN/AN/AN/AN/AOMOutset MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEDAPEdap Tms0.082.181.46NSPRInspireMDN/A6.396.05NXGLNEXGEL0.191.510.93OMOutset Medical4.126.495.04Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEDAPEdap Tms62.74%NSPRInspireMD44.78%NXGLNEXGEL2.21%OMOutset MedicalN/AInsider OwnershipCompanyInsider OwnershipEDAPEdap Tms0.23%NSPRInspireMD29.72%NXGLNEXGEL20.55%OMOutset Medical2.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEDAPEdap Tms23037.39 million37.02 millionOptionableNSPRInspireMD5030.64 million18.33 millionOptionableNXGLNEXGEL107.66 million5.10 millionNot OptionableOMOutset Medical52017.72 million51.50 millionNot OptionableNXGL, OM, EDAP, and NSPR HeadlinesRecent News About These CompaniesRoyal Bank of Canada Forecasts Strong Price Appreciation for Outset Medical (NASDAQ:OM) StockMay 23 at 9:54 AM | marketbeat.comOutset Medical (NASDAQ:OM) Given New $21.00 Price Target at Royal Bank of CanadaMay 23 at 3:01 AM | americanbankingnews.comOutset Medical, Inc. (NASDAQ:OM) CFO Nabeel Ahmed Sells 584 SharesMay 17, 2025 | insidertrades.comOutset Medical Appoints Industry Veteran Kevin O’Boyle to its Board of DirectorsMay 15, 2025 | uk.finance.yahoo.comOutset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of DirectorsMay 14, 2025 | globenewswire.comOutset Medical to Present at RBC Global Healthcare ConferenceMay 9, 2025 | globenewswire.comOutset Medical, Inc. (OM) Q1 2025 Earnings Call TranscriptMay 7, 2025 | seekingalpha.comOutset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue EstimatesMay 7, 2025 | zacks.comOutset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue as Gross Margin Expanded and Cash Use DeclinedMay 7, 2025 | globenewswire.comOUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmApril 29, 2025 | globenewswire.comDoes Outset Medical (OM) Have the Potential to Rally 71.66% as Wall Street Analysts Expect?April 21, 2025 | zacks.comOutset Medical, Inc. Announces Q1 2025 Financial Results Release and Conference Call DetailsApril 16, 2025 | quiverquant.comOutset Medical: The Worst Is Over, But Execution Risk Remains HighApril 16, 2025 | seekingalpha.comAnalysts Conflicted on These Healthcare Names: Outset Medical (OM) and AptarGroup (ATR)April 16, 2025 | markets.businessinsider.comPainful week for individual investors invested in Outset Medical, Inc. (NASDAQ:OM) after 18% drop, institutions also suffered lossesApril 10, 2025 | finance.yahoo.comWall Street Analysts Predict an 188.63% Upside in Outset Medical (OM): Here's What You Should KnowApril 2, 2025 | zacks.comShareholder Alert: Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Outset Medical, Inc. (OM)March 25, 2025 | markets.businessinsider.comShareholder Alert: Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Outset Medical, Inc. (OM)March 25, 2025 | markets.businessinsider.comOutset Medical price target adjusted to $15 at Stifel after reverse stock splitMarch 21, 2025 | markets.businessinsider.comOutset Medical, Inc.: Outset Medical Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 21, 2025 | finanznachrichten.deOutset Medical trading halted, volatility trading pauseMarch 21, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesQualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongBy Sam Quirke | May 13, 2025View Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongWhy D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For QuantumUnitedHealth Insiders Double Down: Is UNH Stock a Value Play?By Jeffrey Neal Johnson | May 19, 2025View UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Broadcom Set to Surge as AI Diffusion Rule EndsBy Leo Miller | May 15, 2025View Broadcom Set to Surge as AI Diffusion Rule EndsWhy Wells Fargo Is Buying $40 Billion of Its Own StockBy Gabriel Osorio-Mazilli | May 6, 2025View Why Wells Fargo Is Buying $40 Billion of Its Own StockNXGL, OM, EDAP, and NSPR Company DescriptionsEdap Tms NASDAQ:EDAP$1.77 -0.03 (-1.67%) Closing price 05/23/2025 03:56 PM EasternExtended Trading$1.77 0.00 (0.00%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.InspireMD NYSE:NSPR$2.53 +0.25 (+10.96%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.44 -0.09 (-3.56%) As of 05/23/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.NEXGEL NASDAQ:NXGL$2.18 -0.07 (-3.11%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.18 0.00 (0.00%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.Outset Medical NASDAQ:OM$17.95 -0.52 (-2.82%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$18.52 +0.57 (+3.20%) As of 05/23/2025 05:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain These ETFs Provide Easy Exposure to Growing International Markets Advance Auto Parts Jumps on Surprise Earnings Beat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
